Colony Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$669K Sell
1,530
-3
-0.2% -$1.5K 0.01% 499
2023
Q2
$770K Buy
1,533
+11
+0.7% +$5.27K 0.01% 485
2023
Q1
$761K Sell
1,522
-33
-2% -$15.8K 0.01% 483
2022
Q4
$634K Sell
1,555
-387
-20% -$150K 0.01% 577
2022
Q3
$633K Sell
1,942
-151
-7% -$55.5K 0.01% 527
2022
Q2
$734K Buy
2,093
+1
+0% +$408 0.01% 521
2022
Q1
$1.14M Hold
2,092
0.02% 460
2021
Q4
$1.38M Sell
2,092
-156
-7% -$97.9K 0.02% 385
2021
Q3
$1.4M Sell
2,248
-49
-2% -$32.9K 0.03% 367
2021
Q2
$1.45M Sell
2,297
-28
-1% -$15.5K 0.03% 342
2021
Q1
$1.14M Sell
2,325
-3
-0.1% -$1.5K 0.02% 380
2020
Q4
$1.16M Sell
2,328
-67
-3% -$30K 0.03% 346
2020
Q3
$941K Sell
2,395
-146
-6% -$54K 0.02% 364
2020
Q2
$839K Buy
2,541
+592
+30% +$171K 0.02% 369
2020
Q1
$472K Buy
1,949
+41
+2% +$10.7K 0.02% 462
2019
Q4
$498K Sell
1,908
-16
-0.8% -$4.22K 0.01% 532
2019
Q3
$523K Buy
1,924
+44
+2% +$12.2K 0.02% 485
2019
Q2
$518K Buy
1,880
+8
+0.4% +$1.97K 0.02% 499
2019
Q1
$419K Sell
1,872
-12
-0.6% -$2.48K 0.02% 433
2018
Q4
$350K Sell
1,884
-24
-1% -$4.92K 0.02% 385
2018
Q3
$476K Buy
1,908
+70
+4% +$17K 0.02% 355
2018
Q2
$401K Sell
1,838
-221
-11% -$45.5K 0.02% 369
2018
Q1
$394K Buy
2,059
+113
+6% +$20.9K 0.02% 360
2017
Q4
$304K Buy
1,946
+174
+10% +$27.4K 0.02% 387
2017
Q3
$276K Sell
1,772
-145
-8% -$22.9K 0.02% 375
2017
Q2
$309K Buy
+1,917
New +$311K 0.02% 332

Other funds holding IDXX

Colony Group's IDXX Position: Q3 2023 in Review

Colony Group reduced its Idexx Laboratories (IDXX) stake by 0.2% in Q3 2023, selling an estimated $1.5K and leaving 1,530 shares worth $669K. The position accounts for 0.01% of the portfolio, ranked #499.

Colony Group first reported a position in IDXX in Q2 2017 and has held it in 26 quarters since. The position peaked at $1.45M in Q2 2021. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Colony Group held 1,530 shares of Idexx Laboratories worth $669K as of Q3 2023.
  • Colony Group sold 3 Idexx Laboratories shares in Q3 2023, an estimated $1.5K.
  • Idexx Laboratories made up 0.01% of Colony Group's portfolio in Q3 2023, its #499 holding.
  • Colony Group first reported a position in Idexx Laboratories in Q2 2017 and has held it in 26 quarters since.
  • Colony Group's Idexx Laboratories position peaked at $1.45M in Q2 2021.
  • 1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.